The recent COVID-19 pandemic and race to develop vaccines against the causative agent, severe acute respiratory syndrome coronavirus 2, has reminded us of the important role that protein glycosylation plays in the mechanisms of pathogen infection and host immune response. CLI caught up with Dr Sanda and Dr Campos (both at Team Scientific Service Group […]
Vyon® porous plastics from Porvair Sciences are the perfect material for filtration applications in the healthcare and medical devicemarket
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes
After two years of successful marketing of Procalcitonin FS, dedicated kits are now available for the DiaSys respons® systems and BioMajesty® JCA-BM6010/C. Procalcitonin FS offers a reliable alternative, when time matters in sepsis management.
MiRXES, a biotechnology company based in Singapore, is relying on a range of INTEGRA pipetting systems to increase the speed and precision of its RT-qPCR workflows. Adam Chiow, Senior Research Officer at MiRXES, explained: “We are using a proprietary RT-qPCR technology platform – ID3EAL™ – to identify new microRNA biomarkers and develop diagnostic kits for […]
Planning for the world’s leading medical trade fair, MEDICA 2022 (14 – 17 November) in Düsseldorf, as well as the parallel No. 1 trade fair for the supplier sector of the medical technology industry, COMPAMED 2022, is gathering momentum. The course of exhibitor registrations so far indicates that participation will be above last year’s level […]
DATE: 23rd – 24th Nov 2022, Virtual
TRIMERO Diagnostics offers, under the brand KLoneus®, IVD CE marked nephelometric assays for testing FREE LIGHT CHAINS (FLC) on Beckman Coulter’s IMMAGE® 800 Immunochemical Systems.
The impact of the microbiome on a person’s health and disease is only slowly being fully realized. Here Bio-Me introduce themselves and their work to factor in the microbiome to the delivery of precision medicine.
Secretoneurin is a small neuropeptide detectable in the blood and is strong predictor for mortality in several patient cohorts with underlying cardiovascular disease. Here, CardiNor introduce themselves and their work to develop a secretoneurin test to use as part of a biomarker panel for cardiovascular disease.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
